Eileen S. Carpenter

3.3k total citations · 1 hit paper
19 papers, 557 citations indexed

About

Eileen S. Carpenter is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Eileen S. Carpenter has authored 19 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Immunology and 7 papers in Surgery. Recurrent topics in Eileen S. Carpenter's work include Pancreatic and Hepatic Oncology Research (14 papers), Pancreatitis Pathology and Treatment (7 papers) and Immune cells in cancer (6 papers). Eileen S. Carpenter is often cited by papers focused on Pancreatic and Hepatic Oncology Research (14 papers), Pancreatitis Pathology and Treatment (7 papers) and Immune cells in cancer (6 papers). Eileen S. Carpenter collaborates with scholars based in United States, Australia and Croatia. Eileen S. Carpenter's co-authors include Howard C. Crawford, Marina Pasca di Magliano, Katelyn L. Donahue, Kristee Brown, Rosa E. Menjivar, Richard Z. Lin, Ashley Velez-Delgado, Christopher J. Halbrook, Fatima Lima and Arvind Rao and has published in prestigious journals such as The Journal of Experimental Medicine, Gastroenterology and Cancer Research.

In The Last Decade

Eileen S. Carpenter

17 papers receiving 549 citations

Hit Papers

Arginase 1 is a key driver of immune suppression in pancr... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eileen S. Carpenter United States 10 271 243 169 127 82 19 557
Xiangdong Zhao China 14 210 0.8× 324 1.3× 120 0.7× 196 1.5× 46 0.6× 24 580
Monica Aasrum Norway 16 260 1.0× 241 1.0× 84 0.5× 96 0.8× 97 1.2× 25 521
Lucie Kopfstein Switzerland 7 298 1.1× 348 1.4× 60 0.4× 100 0.8× 68 0.8× 8 548
Fransky Hantelys France 10 139 0.5× 354 1.5× 51 0.3× 133 1.0× 49 0.6× 12 513
Peihong Ma United States 7 128 0.5× 240 1.0× 198 1.2× 130 1.0× 27 0.3× 8 487
Sun Y. Kim United States 6 174 0.6× 319 1.3× 55 0.3× 168 1.3× 97 1.2× 6 571
Sarah Short United States 6 170 0.6× 271 1.1× 55 0.3× 115 0.9× 43 0.5× 10 481
Jean-Charles Neel Canada 4 170 0.6× 303 1.2× 77 0.5× 178 1.4× 26 0.3× 6 483
Jessica Lauriol United States 12 211 0.8× 500 2.1× 275 1.6× 57 0.4× 35 0.4× 13 680
Raquel Batlle Spain 7 227 0.8× 345 1.4× 87 0.5× 190 1.5× 50 0.6× 7 552

Countries citing papers authored by Eileen S. Carpenter

Since Specialization
Citations

This map shows the geographic impact of Eileen S. Carpenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen S. Carpenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen S. Carpenter more than expected).

Fields of papers citing papers by Eileen S. Carpenter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen S. Carpenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen S. Carpenter. The network helps show where Eileen S. Carpenter may publish in the future.

Co-authorship network of co-authors of Eileen S. Carpenter

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen S. Carpenter. A scholar is included among the top collaborators of Eileen S. Carpenter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen S. Carpenter. Eileen S. Carpenter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Espinoza, Carlos E., Megan T. Hoffman, Katelyn L. Donahue, et al.. (2025). Fibroblast STAT3 Activation Drives Organ-Specific Premetastatic Niche Formation. Cancer Research. 86(1). 22–39.
2.
Philips, George, Erik Wamsteker, Richard S. Kwon, et al.. (2025). Histologic Diagnosis of Pancreatic Cystic Lesions with Endoscopic Ultrasound Fine Needle Biopsy and Impact on Management Decisions. Digestive Diseases and Sciences. 70(8). 2873–2881. 2 indexed citations
3.
Shannon, Carol, Eileen S. Carpenter, Jiaqi Shi, et al.. (2024). Global Prevalence of Pancreatic Cystic Lesions in the General Population on Magnetic Resonance Imaging: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 22(9). 1798–1809.e6. 15 indexed citations
4.
Chalhoub, Jean M., et al.. (2024). Effect of the number of passes on diagnostic performance of EUS fine-needle biopsy of solid pancreatic masses: a systematic review and meta-analysis. Gastrointestinal Endoscopy. 100(4). 595–604.e8. 7 indexed citations
5.
Carpenter, Eileen S., et al.. (2024). Endoscopic Ultrasound-Guided Ablation of Premalignant Pancreatic Cysts and Pancreatic Cancer. Diagnostics. 14(5). 564–564. 6 indexed citations
6.
Radyk, Megan D., Padma Kadiyala, Jiaqi Shi, et al.. (2024). Metabolic landscape of the healthy pancreas and pancreatic tumor microenvironment. JCI Insight. 9(18). 5 indexed citations
7.
Carpenter, Eileen S., Débora B. Vendramini‐Costa, Anirban Maitra, et al.. (2024). Pancreatic Cancer–Associated Fibroblasts: Where Do We Go from Here?. Cancer Research. 84(21). 3505–3508. 8 indexed citations
8.
Menjivar, Rosa E., Zeribe C. Nwosu, Wenting Du, et al.. (2023). Arginase 1 is a key driver of immune suppression in pancreatic cancer. eLife. 12. 96 indexed citations breakdown →
9.
Menjivar, Rosa E., Nina G. Steele, Samantha B. Kemp, et al.. (2023). Notch Signaling Regulates Immunosuppressive Tumor-Associated Macrophage Function in Pancreatic Cancer. Cancer Immunology Research. 12(1). 91–106. 21 indexed citations
10.
Donahue, Katelyn L., Arvind Rao, Eileen S. Carpenter, et al.. (2023). Abstract PR03: Hypoxia promotes inflammatory fibroblast formation in pancreatic cancer. Cancer Immunology Research. 11(12_Supplement). PR03–PR03. 1 indexed citations
12.
Donahue, Katelyn L., Arvind Rao, Eileen S. Carpenter, et al.. (2022). Hypoxia promotes an inflammatory phenotype of fibroblasts in pancreatic cancer. Oncogenesis. 11(1). 56–56. 45 indexed citations
13.
Du, Wenting, Rosa E. Menjivar, Katelyn L. Donahue, et al.. (2022). WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer. The Journal of Experimental Medicine. 220(1). 35 indexed citations
14.
Kadiyala, Padma, et al.. (2022). Using Single Cell Transcriptomics to Elucidate the Myeloid Compartment in Pancreatic Cancer. Frontiers in Oncology. 12. 881871–881871. 3 indexed citations
15.
Kemp, Samantha B., Eileen S. Carpenter, Nina G. Steele, et al.. (2021). Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB–Mediated Production of CXCL1. Cancer Research. 81(16). 4305–4318. 112 indexed citations
16.
Carpenter, Eileen S., Sarah C. Nelson, Filip Bednar, et al.. (2021). Immunotherapy for pancreatic ductal adenocarcinoma. Journal of Surgical Oncology. 123(3). 751–759. 21 indexed citations
17.
Carpenter, Eileen S., Kenneth K. Takeuchi, Christopher J. Halbrook, et al.. (2014). PI3K Regulation of RAC1 Is Required for KRAS-Induced Pancreatic Tumorigenesis in Mice. Gastroenterology. 147(6). 1405–1416.e7. 88 indexed citations
18.
Lu, Zhongju, Yaping Jiang, Lisa M. Ballou, et al.. (2013). Increased Persistent Sodium Current Due to Decreased PI3K Signaling Contributes to QT Prolongation in the Diabetic Heart. Diabetes. 62(12). 4257–4265. 68 indexed citations
19.
Bombardelli, Lorenzo, et al.. (2010). Pancreas-Specific Ablation of β1 Integrin Induces Tissue Degeneration by Disrupting Acinar Cell Polarity. Gastroenterology. 138(7). 2531–2540.e4. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026